Suven Pharmaceuticals Ltd
NSE:SUVENPHAR

Watchlist Manager
Suven Pharmaceuticals Ltd Logo
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Watchlist
Price: 1 259.15 INR -2.18% Market Closed
Market Cap: 320.5B INR
Have any thoughts about
Suven Pharmaceuticals Ltd?
Write Note

Suven Pharmaceuticals Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Suven Pharmaceuticals Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Depreciation & Amortization
â‚ą518.1m
CAGR 3-Years
18%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Depreciation & Amortization
â‚ą14.7B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Depreciation & Amortization
â‚ą10.4B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Depreciation & Amortization
â‚ą25.5B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Depreciation & Amortization
â‚ą8.1B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Depreciation & Amortization
â‚ą4B
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Suven Pharmaceuticals Ltd
Glance View

Market Cap
320.5B INR
Industry
Pharmaceuticals

Suven Pharmaceuticals Ltd. manufactures chemical products. The company is headquartered in Hyderabad, Telangana and currently employs 1,193 full-time employees. The company went IPO on 2020-03-09. The firm operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe and Rest of the World. In India, the Company sells bulk drugs and intermediates, fine chemicals and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In Rest of the World, the Company sells bulk drugs, intermediates and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

SUVENPHAR Intrinsic Value
402.41 INR
Overvaluation 68%
Intrinsic Value
Price

See Also

What is Suven Pharmaceuticals Ltd's Depreciation & Amortization?
Depreciation & Amortization
518.1m INR

Based on the financial report for Mar 31, 2024, Suven Pharmaceuticals Ltd's Depreciation & Amortization amounts to 518.1m INR.

What is Suven Pharmaceuticals Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
35%

Over the last year, the Depreciation & Amortization growth was 12%. The average annual Depreciation & Amortization growth rates for Suven Pharmaceuticals Ltd have been 18% over the past three years , 35% over the past five years .

Back to Top